Featured Insight

Global Financial and Economic Crime Outlook 2025

April 10, 2025

Search Insights

Latest Insights

See All Insights

Events

Securities Enforcement Forum DC 2025

October 30, 2025

On October 30, Managing Director Norman Harrison will  be speaking at Securities Enforcement Forum DC 2025 on the panel “Corporate Crisis Management: How to Handle a Major Internal Investigation and/or Whistleblower.

Read More

SCCE Dallas Regional Compliance & Ethics Conference

October 17, 2025

Join Managing Director Brent McDaniel and Scott Mascianica (Hilgers Graben) on October 17 for “Whistling Down the Wire: Analysis of Recent Whistleblower and Hotline Trends” at the SCCE Dallas Regional Compliance & Ethics Conference.

Read More
See All Events
featured Engagements

Biopharmaceutical Reasonable Royalties on Trial

When our client, a biopharmaceutical company, had exclusively licensed a patent for a novel type of cancer immunotherapy, a competitor undertook substantial efforts to be first to market for its lead indication despite being aware of potential infringement claims against its therapy. Upon the competitor achieving FDA approval, our client filed patent infringement claims. After an eight-day trial, the jury returned a verdict in favor of our client with a damages award that precisely matched the trial testimony.

Read More
View All Engagements

Media Contact

If you would like to schedule an interview or would like more information about our firm and individual experts, please contact:

Nathan Jenks
Director of Marketing & Communications
Email: njenks@secretariat-intl.com